1. Home
  2. NPCE vs VALN Comparison

NPCE vs VALN Comparison

Compare NPCE & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$16.31

Market Cap

623.0M

Sector

Health Care

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$5.85

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPCE
VALN
Founded
1997
2012
Country
United States
France
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
623.0M
536.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
NPCE
VALN
Price
$16.31
$5.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$18.33
$15.50
AVG Volume (30 Days)
199.4K
69.2K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
29.03
N/A
EPS
N/A
N/A
Revenue
$99,986,000.00
N/A
Revenue This Year
$0.90
N/A
Revenue Next Year
$24.46
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
25.13
N/A
52 Week Low
$7.56
$5.06
52 Week High
$19.60
$12.25

Technical Indicators

Market Signals
Indicator
NPCE
VALN
Relative Strength Index (RSI) 50.13 48.72
Support Level $15.17 $5.81
Resistance Level $17.04 $6.53
Average True Range (ATR) 1.17 0.25
MACD -0.24 0.12
Stochastic Oscillator 42.86 53.46

Price Performance

Historical Comparison
NPCE
VALN

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: